What “99% Purity” Actually Measures
Every peptide supplier publishes a purity figure. Almost none explains what it is a percentage of. HPLC purity and net peptide content are two different measurements with two different denominators — and a vial can honestly be 99% pure and 81% peptide by mass at the same time.
Two numbers, two denominators
The confusion is not that one figure is right and the other wrong. Both are correct measurements. They answer different questions, and the answers are not interchangeable.
HPLC purity
target peak area ÷ total detected peak area
Determined by reversed-phase HPLC with UV detection, usually at 214 nm where the peptide bond absorbs. It compares your target sequence against other things the detector can see — truncated chains, deletion sequences, oxidized variants. Anything transparent at that wavelength is invisible to it.
Net peptide content
mass of peptide ÷ total mass of powder
Determined by amino acid analysis or nitrogen determination. It compares peptide against everything else in the vial, including what HPLC cannot see: counterion salt, bound water, residual solvent. This is the figure that tells you how much peptide you actually have.
The single-sentence version
HPLC purity asks “of the peptide-derived material present, how much is the right sequence?” Net peptide content asks “of this powder, how much is peptide at all?”
A high answer to the first says nothing about the second, because the things that lower net peptide content are chemically invisible to the assay that produces the first.
Four things occupy the mass that is not peptide
None of the first three is a defect, a contaminant, or a sign of poor synthesis. They are the normal residue of how purified peptides are made and stored. The fourth is different, and it is the one HPLC is built to catch.
Counterion salt
Reversed-phase purification uses trifluoroacetic acid as an ion-pairing agent. Every basic site — each lysine, arginine, histidine, and the N-terminus — retains a TFA counterion when the material is dried. More basic residues means proportionally more salt, and salt is heavy.
Residual water
Lyophilized peptides are hygroscopic. Even sealed and desiccated, a freeze-dried cake holds bound water and takes on more with every exposure to room air. Measured separately by Karl Fischer titration, and a standard field on a thorough certificate.
Residual solvent
Trace acetonitrile and other process solvents survive lyophilization in small amounts. Limits are set by ICH Q3C class and testing is by gas chromatography. Usually a minor share of the mass — but it is mass, and it belongs on the accounting.
Related substances
Deletion sequences, truncations, and oxidized or deamidated variants — the by-products of synthesis. These do absorb at 214 nm, so they appear as their own peaks and count directly against the HPLC figure. This is the fraction a purity percentage genuinely reports on.
One vial, both numbers, no contradiction
An illustrative 10 mg vial of a 15-residue peptide of molecular weight 1498.6 g/mol with two basic sites, supplied as the TFA salt. Every line below can be checked against those two facts.
Both figures describe this vial correctly
The 99.2% is a statement about the 8.15 mg of peptide-derived material: of everything the detector saw, 99.2% of the peak area was the target sequence and 0.8% was related substances. The 81.5% is a statement about the whole 10 mg.
Work it back if you like: 10.00 less water and trace leaves 9.39 mg of salt-form peptide, of which 13.2% is counterion. Salt and water never entered the first calculation because they do not absorb at 214 nm.
How mass distributes in a lyophilized TFA-salt peptide
Ranges rather than fixed values, because the largest variable is the peptide itself: counterion load scales with the number of basic residues, so two peptides purified identically can differ by ten points of net peptide content.
What each measurement can and cannot tell you
| HPLC purity | Net peptide content | |
|---|---|---|
| Reports | Area percent of detected material | Mass percent of the powder |
| Method | RP-HPLC with UV detection, typically 214 nm | Amino acid analysis, or nitrogen determination |
| Answers | Is this the right sequence, and how clean is the synthesis? | How much peptide is in this vial? |
| Sees salt | No | Yes |
| Sees water | No | Yes |
| Sees deletion sequences | Yes | No — still peptide by mass |
| Typical value | 95–99.9% area | 70–85% mass |
| Commonly published | Almost always | Rarely |
Each is blind where the other sees
HPLC catches a bad synthesis and misses a heavily salted one. Net peptide content catches the salt and would not notice if a fifth of your material were a deletion sequence, because a deletion sequence is still peptide by mass.
That is why a certificate carrying only one of them is incomplete — not dishonest, but unable to answer half the question.
Where the gap changes your results
The difference between the two figures is not academic. It propagates directly into anything calculated from the mass of powder you weighed.
Concentration
Derive a working concentration by weighing powder and assuming it is all peptide, and the true concentration is low by the whole net content gap. The error is systematic, so it will not average out across replicates.
Batch comparability
Two batches at the same HPLC purity can differ in net peptide content if counterion load or water content differs. Comparing across them attributes a mass difference to a biological one.
Supplier comparison
Two suppliers both publishing 99% purity are not necessarily offering the same peptide per milligram. Without net content on both certificates, the figures are not comparable on the thing that differs.
Salt form changes
The same sequence as an acetate salt rather than a TFA salt has a different mass balance and a different net peptide content, at identical chromatographic purity. Salt form belongs on the certificate for this reason.
What a complete certificate carries
An omission is not evidence of a problem — amino acid analysis costs money and most of the market never commissions it. But it does mean the question is unanswered, and a figure you cannot see is not a figure you can rely on.
| Field | What it establishes | Commonly omitted? |
|---|---|---|
| Batch or lot number | That the document describes the vial in your hand, not a representative sample | Rarely |
| HPLC purity + method | Chromatographic purity, and the wavelength and gradient it was measured at | Rarely |
| Chromatogram | Lets you see peak shape and shoulders rather than trusting a single number | Often |
| Mass spec identity | That the molecule is the intended sequence, not merely a pure something | Sometimes |
| Net peptide content | How much of the powder is peptide | Usually |
| Water content | The Karl Fischer figure feeding the mass balance | Usually |
| Counterion and salt form | Which salt, and therefore the expected mass contribution | Usually |
| Test date and analyst | That the analysis is current and attributable | Sometimes |
Purity and peptide content
If net peptide content is only 80%, is the supplier overstating purity?
No. The two figures measure different things and both can be accurate at once. A 99% purity claim is a statement about chromatographic purity — the proportion of detected material that is the target sequence. It was never a claim about the mass composition of the vial. Overstatement would be presenting an HPLC figure as though it described the mass, which is a labeling problem rather than an analytical one.
Why is TFA present at all if it lowers the peptide content?
Trifluoroacetic acid is the standard ion-pairing agent in reversed-phase purification, and it is a large part of why high chromatographic purity is achievable. The counterion that remains is a consequence of the process that produced the purity. Salt exchange to an acetate form is possible and is sometimes performed where TFA is undesirable, but it is an additional step with its own yield cost.
Can I calculate net peptide content myself from the sequence?
You can estimate the counterion contribution, because it follows from the number of basic sites and the molecular weight of the counterion. You cannot estimate the water content, which varies with handling and storage history and has to be measured. So an estimate gives you the shape of the gap but not its size, and it will always read higher than reality.
Does high purity mean the compound is the right molecule?
Not by itself. Chromatographic purity establishes that one species dominates the chromatogram; it does not establish which species. Identity is a separate question answered by mass spectrometry, comparing observed mass against the theoretical mass for the sequence. A sample can be highly pure and not be what the label says.
Which figure should I ask a supplier for?
Both, with the method for each, and a batch number tying them to your vial. If only one is available, knowing which one you are looking at is the important part — more so than the value itself, because a figure interpreted as the wrong quantity is worse than no figure.
Does a higher purity percentage always mean better material?
Between 95% and 99% the difference is meaningful for reproducibility. Above that, differences are often within the variability of the assay itself, and the wavelength and gradient used can move the number as much as the material does. This is why the method matters alongside the figure, and why a chromatogram is more informative than a percentage.
Every batch documented, domestically shipped
NuMe supplies HPLC-verified, batch-documented research compounds to Canadian laboratories and institutions, shipped domestically so material spends less time in transit.
Explore the CatalogueDisclaimer: This page is provided for educational and informational purposes only. It does not constitute medical advice, and it contains no guidance on the use of any compound in people. All NuMe products are supplied strictly for laboratory research and in-vitro testing. They are not approved for human consumption, veterinary use, or any therapeutic application. Peptides are generally regulated as prescription drugs in Canada. Individuals seeking peptide therapy should consult a licensed healthcare practitioner.
